The challenger to Intuitive Surgical said its Maestro platform has aided in more than 1,600 surgeries to date, with the majority performed in the past year.
Moon Surgical hires 3 executives for soft tissue robot expansion push Read More »
The newly appointed members of the CDC’s influential vaccine committee meet Wednesday and Thursday under an unusually rapid timeline, with unexpected topics on the agenda.
Tapping into the hidden job market can be challenging but is important in today’s employer-driven market. Three talent acquisition experts share tips for accessing hard-to-find roles.
Finding Your Next Role: 5 Ways To Uncover Hidden Jobs Read More »
The FDA is assessing the need for “further regulatory action” on Sarepta’s Duchenne muscular dystrophy gene therapy in the aftermath of two patient deaths, though the regulator has not yet specified what action this could be.
FDA Reviews Sarepta’s Elevidys After Second Patient Death Read More »
Gilead is betting up to $750 million on Kymera’s anti-CDK2 molecular glue for solid tumors, while Sanofi elected to move forward with another protein degrader from the biotech, designed to target immune-mediated diseases.
Sanofi, Gilead Deepen Protein Degrader Pipelines in Separate Deals With Kymera Read More »
Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be three times larger than what AbbVie’s blockbuster Humira ever achieved.
Prescription Drug Sales Will Hit $1.75T By 2030 Thanks to GLP-1s: Evaluate Read More »
El yacimiento paleontológico de Dmanisi, en Georgia, es uno de los más importantes de ese país del Cáucaso. El yacimiento es el más antiguo de Eurasia con restos humanos, datando de hace 1,8 millones de años. Un estudio reciente en ese yacimiento ha revelado …
Abundantes restos de mamuts en el yacimiento paleontológico de Dmanisi Read More »
Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of clear differentiation” for rezpegaldesleukin in the atopic dermatitis space.
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced Read More »
Mike Davis previously worked as clinical team leader at the FDA’s Division of Psychiatry before serving as chief medical officer for Usona Institute, a research organization advancing psychedelic science.
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open Read More »
In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs Read More »
